Literature DB >> 24041801

Flow cytometric analysis for detection of tumor-initiating cells in feline mammary carcinoma cell lines.

Masaki Michishita1, Aya Otsuka, Rei Nakahira, Takayuki Nakagawa, Nobuo Sasaki, Toshiro Arai, Kimimasa Takahashi.   

Abstract

A small population of cells known as tumor-initiating cells (TICs), which have the capacity to self-renew, differentiate, and form tumors at high frequency, has a potential role in tumor initiation, aggression, and recurrence. In human breast cancers, TICs are identified by surface markers, such as CD44 and CD24, and an aldefluor assay based on aldehyde dehydrogenase activity (ALDH(+)) using flow cytometry. However, the usefulness of surface markers CD44 and CD24 and ALDH activity in feline mammary carcinomas remains largely elusive. We attempted to identify CD44(+)CD24(-) and ALDH(+) cells using 8 feline mammary carcinoma cell lines, including FKNp, which was obtained from a primary lesion, and the capacity to generate tumor nodules was analyzed in immunodeficient mice injected with ALDH(+) FKNp-derived cells. The CD44(+)CD24(-) and ALDH(+) cells were detected in all cell lines derived from feline mammary carcinomas. Xenograft transplantation into immunodeficient mice demonstrated that as few as 1 × 10(2) ALDH(+) cells could initiate tumor growth in 1 out of 4 mice, while 1 × 10(3) ALDH(+) cells initiated tumor growth in 5 out of 6 mice. However, 1 × 10(3) ALDH(-) cells failed to initiate tumors in all the tested mice. ALDH(+)-derived tumors contained both ALDH(+) and ALDH(-) cells, indicating that ALDH(+) FKNp-derived cells had higher tumorigenicity than ALDH(-) cells. These results suggest that TICs may exist in feline mammary carcinomas, and further characterization of CD44(+)CD24(-) and ALDH(+) cells is needed to define novel therapies targeted against TICs. This study provides the foundation for elucidating the contribution of TICs in tumorigenesis.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cat; Flow cytometry; Mammary carcinoma; Tumor-initiating cells; Xenograft

Mesh:

Substances:

Year:  2013        PMID: 24041801     DOI: 10.1016/j.vetimm.2013.08.006

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  2 in total

1.  Flow cytometry expression pattern of CD44 and CD18 markers on feline leukocytes.

Authors:  Valeria Martini; Serena Bernardi; Alessia Giordano; Stefano Comazzi
Journal:  J Vet Diagn Invest       Date:  2020-07-28       Impact factor: 1.279

2.  TiHo-0906: a new feline mammary cancer cell line with molecular, morphological, and immunocytological characteristics of epithelial to mesenchymal transition.

Authors:  José Luis Granados-Soler; Johannes Junginger; Marion Hewicker-Trautwein; Kirsten Bornemann-Kolatzki; Julia Beck; Bertram Brenig; Daniela Betz; Jan Torben Schille; Hugo Murua Escobar; Ingo Nolte
Journal:  Sci Rep       Date:  2018-09-05       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.